A photo of Susanne Wells.

Director, Epithelial Carcinogenesis and Stem Cell Program

Professor, UC Department of Pediatrics



Biography & Affiliation


Susanne Wells graduated from the University of Konstanz, Germany, with a degree in Biology. She completed her PhD in Molecular Genetics and Microbiology at the State University of Stony Brook, NY, and her Postdoctoral Fellowship at Harvard Medical School, MA. Dr. Wells moved to Cincinnati Children's Hospital Medical Center in 2002 to study epithelial carcinogenesis and stem cells.

Academic Affiliation

Professor, UC Department of Pediatrics


Experimental Hematology and Cancer Biology, Oncology, Cancer and Blood Diseases


BS: Biology, University of Konstanz, Germany, 1992.

PhD: Molecular Genetics, State University of Stony Brook, NY, 1997.

Postdoctoral Fellowship: Molecular Virology, Harvard Medical School, Boston, MA.


Lipidomic Profiling Links the Fanconi Anemia Pathway to Glycosphingolipid Metabolism in Head and Neck Cancer Cells. Zhao, X; Brusadelli, MG; Sauter, S; Kovacic, MB; Zhang, W; Romick-Rosendale, LE; Lambert, PF; Setchell, KD R; Wells, SI. Clinical Cancer Research. 2018; 24:2700-2709.

Risk of Human Papillomavirus Infection in Cancer-Prone Individuals: What We Know. Khoury, R; Sauter, S; Kovacic, MB; Nelson, AS; Myers, KC; Mehta, PA; Davies, SM; Wells, SI. Viruses-Basel. 2018; 10:47-47.

Impaired immune function in children and adults with Fanconi anemia. Myers, KC; Sauter, S; Zhang, X; Bleesing, JJ; Davies, SM; Wells, SI; Mehta, PA; Kumar, A; Marmer, D; Marsh, R; et al. Pediatric Blood and Cancer. 2017; 64:e26599-e26599.

Overexpression of the human DEK oncogene reprograms cellular metabolism and promotes glycolysis. Matrka, MC; Watanabe, M; Muraleedharan, R; Lambert, PF; Lane, AN; Romick-Rosendale, LE; Wells, SI. PLoS ONE. 2017; 12:e0177952-e0177952.

DEK associates with tumor stage and outcome in HPV16 positive oropharyngeal squamous cell carcinoma. Smith, EA; Kumar, B; Komurov, K; Smith, SM; Brown, NV; Zhao, S; Kumar, P; Teknos, TN; Wells, SI. Oncotarget. 2017; 8:23414-23426.

DEK is required for homologous recombination repair of DNA breaks. Smith, EA; Gole, B; Willis, NA; Soria, R; Starnes, LM; Krumpelbeck, EF; Jegga, AG; Ali, AM; Guo, H; Meetei, AR; et al. Scientific Reports. 2017; 7.

PLK1 inhibition enhances temozolomide efficacy in IDH1 mutant gliomas. Koncar, RF; Chu, Z; Romick-Rosendale, LE; Wells, S; Chan, TA; Qi, X; Bahassi, EM. Oncotarget. 2017; 8:15827-15837.

Defects in the Fanconi Anemia Pathway in Head and Neck Cancer Cells Stimulate Tumor Cell Invasion through DNA-PK and Rac1 Signaling. Romick-Rosendale, LE; Hoskins, EE; Vinnedge, LM P; Foglesong, GD; Brusadelli, MG; Potter, SS; Komurov, K; Brugmann, SA; Lambert, PF; Kimple, RJ; et al. Clinical Cancer Research. 2016; 22:2062-2073.

The cyclic GMP/protein kinase G pathway as a therapeutic target in head and neck squamous cell carcinoma. Tuttle, TR; Mierzwa, ML; Wells, SI; Fox, SR; Ben-Jonathan, N. Cancer Letters. 2016; 370:279-285.

Overcoming Pluripotent Stem Cell Dependence on the Repair of Endogenous DNA Damage. Chlon, TM; Ruiz-Torres, S; Maag, L; Mayhew, CN; Wikenheiser-Brokamp, KA; Davies, SM; Mehta, P; Myers, KC; Wells, JM; Wells, SI. Stem Cell Reports. 2016; 6:44-54.